Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹9 Cr
P/E Ratio
--
P/B Ratio
1.83
Industry P/E
--
Debt to Equity
1.11
ROE
12.54 %
ROCE
10.18 %
Div. Yield
0 %
Book Value
1.24
EPS
-0.02
CFO
₹2.39 Cr
EBITDA
₹1.61 Cr
Net Profit
₹0.69 Cr
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Vivanza Bioscience
| -33.63 | 14.07 | -24.33 | -72.08 | -49.63 | -- | 16.04 |
|
BSE Healthcare
| -6.54 | 1.91 | 4.84 | 19.10 | 20.06 | 22.35 | 10.14 |
|
BSE Small Cap
| -11.96 | 3.43 | 1.57 | 2.12 | 18.79 | 34.74 | 16.10 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
|
|---|---|---|---|---|---|
|
Vivanza Bioscience
| -69.38 | -30.55 | -12.92 | 55.94 | 759.11 |
|
BSE Small Cap
| 29.04 | 47.52 | -1.80 | 62.77 | 32.11 |
|
BSE Healthcare
| 43.09 | 36.97 | -12.10 | 20.87 | 61.45 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
|---|---|---|---|---|
| 1,344.40 | 5,850.70 | 64.94 | 5.43 | |
| 41.96 | 52.32 | -- | -2.76 | |
| 48.97 | 30.72 | 130.71 | 2.52 | |
| 9.14 | 102.84 | 54.41 | 3.66 |
No Review & Analysis are available.
Wholesale of pharmaceutical and medical goods
Incorporated
1982
Chairman
--
Managing Director
Jayendra Mehta
Headquarters
Ahmedabad, Gujarat
Website
Looking for more details about Vivanza Biosciences Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View Announcements
The total asset value of Vivanza Biosciences Ltd stood at ₹ 22 Cr as on 31-Dec-24
The share price of Vivanza Biosciences Ltd is ₹2.27 (BSE) as of 29-Apr-2025 IST. Vivanza Biosciences Ltd has given a return of -49.63% in the last 3 years.
Vivanza Biosciences Ltd has a market capitalisation of ₹ 9 Cr as on 29-Apr-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Vivanza Biosciences Ltd is 1.83 times as on 29-Apr-2025, a 0% premium to its peers’ median range of 1.83 times.
Since, TTM earnings of Vivanza Biosciences Ltd is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Vivanza Biosciences Ltd and enter the required number of quantities and click on buy to purchase the shares of Vivanza Biosciences Ltd.
Wholesale of pharmaceutical and medical goods
The promoter of Vivanza Biosciences Ltd is PARTH HEMANT PARIKH. PARTH HEMANT PARIKH owns 19.77 per cent of the total equity. The chairman of the company is , and the managing director is Jayendra Mehta..
There is no promoter pledging in Vivanza Biosciences Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
5,753
|
|
|
93
|
|
|
55
|
|
|
34
|
| Vivanza Biosciences Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
-1.9
|
|
Operating margin(%)
|
3.83
|
|
Net Margin(%)
|
-0.8
|
|
Dividend yield(%)
|
0
|
No, TTM profit after tax of Vivanza Biosciences Ltd was ₹0 Cr.
₹-0.02
(
